Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 3/20 | 0.47 |
| ▸ | BCR | P11274 | 3/20 | 0.47 |
| ▸ | SRC | P12931 | 3/20 | 0.47 |
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | PRKACA | P17612 | 2/20 | 0.47 |
| ▸ | PRKACG | P22612 | 2/20 | 0.47 |
| ▸ | PRKACB | P22694 | 2/20 | 0.47 |
| ▸ | CAMK2D | Q13557 | 2/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 2/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | SYK | P43405 | 3/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.41 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.41 |
| ▸ | CDK1 | P06493 | 2/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL1244577 | 0.83 | ALDH1A1 (0.40) | ABL1BCREGFRCDK5CDK2 | |
| Trifluoroacetic Acid SCHEMBL1244880 | 0.79 | AURKA (0.41) | ABL1BCRSRCEGFRCDK2 | |
| Trifluoroacetic Acid SCHEMBL1242168 | 0.75 | PIP4K2C (0.45) | EGFRCCNT1CDK9 | |
| Trifluoroacetic Acid SCHEMBL1243690 | 0.75 | CYP1A2 (0.41) | ABL1BCRCCNT1CDK9 | |
| SCHEMBL25337558 | 0.73 | ABL1 (0.63) | ABL1BCRSRCEGFRPRKACA | |
| SCHEMBL31118904 | 0.73 | ABL1 (0.63) | ABL1BCRSRCEGFRPRKACA | |
| Trifluoroacetic Acid SCHEMBL1244552 | 0.72 | PTGS1 (0.43) | ABL1BCREGFRCCNT1CDK9 | |
| Trifluoroacetic Acid SCHEMBL1242021 | 0.72 | PIP4K2C (0.49) | ABL1BCREGFRCCNT1CDK9 | |
| SCHEMBL1242170 | 0.71 | ABL1 (0.36) | ABL1BCREGFRCDK5CDK2 | |
| SCHEMBL1241964 | 0.71 | ABL1 (0.40) | ABL1BCRSRCEGFRCDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7879853-B2 | tyrosisne kinase inhibitors such as N-[4-(6-Dibenzofuran-4-yl-pyrimidin-4-ylamino)-phenyl]-4-morpholin-4-yl-benzamide, used as anticasrcinogenic or antoproliferative agents, especially in the treatment of breast cancer | BAYER SCHERING PHARMA AG (DE) | 2011-02-01 | — | — | US | disclosed |
| US-20070208034-A1 | 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors | ATLANTA PHARMA AG (DE) | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208034-A1 | 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors | CDK2, DCK, DTYMK | ABL1 55/4885BCR 844/4885SRC 406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.